Post-approval studies (Phase 4)Study completedNCT06587386
What this trial is testing
The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function
Who this might be right for
Motion Sickness
Affiliated Hospital of Jiaxing University 55